Watertown, MA
Progentos Therapeutics develops an approach to treat multiple sclerosis that stimulates the body's natural repair mechanisms.
progentos.comThese are collections Progentos is a part of. Click on the collection name to view similar companies.
Series A
$65,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Progentos.